{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:02:56Z","timestamp":1785358976005,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100023452","name":"Hanarth Fund Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijgc.2026.104721","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:06:57Z","timestamp":1776899217000},"page":"104721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human epididymis protein 4 and risk of malignancy index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch health care perspective"],"prefix":"10.1016","volume":"36","author":[{"given":"Pien","family":"Lof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone N.","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stiekema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrthe","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guus","family":"Fons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-0942","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon D.J.M.","family":"van Gent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2838-2031","authenticated-orcid":false,"given":"Constantijne H.","family":"Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur M.F.","family":"Rosier-van Dunn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelmina M.","family":"van Baal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold R.","family":"Verhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda B.J.","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn B.","family":"Verbruggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majoie","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jojanneke M.G.","family":"van de Swaluw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haye C.","family":"Knipscheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A.F.","family":"Huirne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Westenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valesca P.","family":"Ret\u00e8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-7299","authenticated-orcid":false,"given":"Christianne A.R.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijgc.2026.104721_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2017.11.009","article-title":"Centralization of ovarian cancer in the Netherlands: hospital of diagnosis no longer determines patients\u2019 probability of undergoing surgery","volume":"148","author":"Timmermans","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104721_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ygyno.2016.04.012","article-title":"Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands","volume":"141","author":"Eggink","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104721_bib3","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.3747\/co.22.2482","article-title":"The optimal organization of gynecologic oncology services: a systematic review","volume":"22","author":"Fung-Kee-Fung","year":"2015","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104721_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ygyno.2012.04.012","article-title":"Centralisation of services for gynaecological cancers - a Cochrane systematic review","volume":"126","author":"Woo","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ijgc.2026.104721_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104721_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","article-title":"The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals","volume":"93","author":"Tingulstad","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ijgc.2026.104721_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5920","article-title":"Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study","volume":"349","author":"Van Calster","year":"2014","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104721_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/172460089801300411","article-title":"CA 125 in benign gynecological conditions","volume":"13","author":"Meden","year":"1998","journal-title":"Int J Biol Markers"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104721_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/1096-9098(200012)75:4<264::AID-JSO7>3.0.CO;2-Q","article-title":"Benign conditions associated with raised serum CA-125 concentration","volume":"75","author":"Buamah","year":"2000","journal-title":"J Surg Oncol"},{"issue":"13","key":"10.1016\/j.ijgc.2026.104721_bib10","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104721_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.101713","article-title":"Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses","volume":"49","author":"Aslan","year":"2020","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104721_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11596-020-2163-7","article-title":"Ultrasound features improve diagnostic performance of ovarian cancer predictors in distinguishing benign and malignant ovarian tumors","volume":"40","author":"Chen","year":"2020","journal-title":"Curr Med Sci"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104721_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ygyno.2022.05.025","article-title":"Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital?","volume":"166","author":"Lof","year":"2022","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ijgc.2026.104721_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0272989X16686559","article-title":"An overview of R in health decision sciences","volume":"37","author":"Jalal","year":"2017","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.ijgc.2026.104721_bib15","series-title":"The Measurement and Valuation of Health Status using EQ-5D: a European Perspective: Evidence From the EuroQol BIOMED Research Programme","year":"2003"},{"key":"10.1016\/j.ijgc.2026.104721_bib16","series-title":"Manual for Cost Analyses, Methods and Standard Prices for Economic Evaluations in Health Care - Zorginstituut Nederland (The National Health Care Intitute)","author":"Hakkaart-van Roijen","year":"2015"},{"key":"10.1016\/j.ijgc.2026.104721_bib17","unstructured":"Dutch Healthcare Authority (Nederlandse Zorgautoriteit, NZa). Pricelist Healthcare Products; 2019 (Tarievenlijst DBC-zorgproducten en overige 2019). https:\/\/nza.nl Accessed: 2019"},{"key":"10.1016\/j.ijgc.2026.104721_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2015.11.005","article-title":"Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis","volume":"54","author":"Shim","year":"2016","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104721_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/bjc.2014.648","article-title":"Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study","volume":"112","author":"Trillsch","year":"2015","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104721_bib20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/IGC.0000000000000722","article-title":"The evaluation of risk factors associated with relapse and recurrence of borderline ovarian tumors with long-term follow-up","volume":"26","author":"Sobiczewski","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104721_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/humupd\/dmt059","article-title":"Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis","volume":"20","author":"Kaijser","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ijgc.2026.104721_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis","volume":"58","author":"Meys","year":"2016","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104721_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/uog.12308","article-title":"Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature","volume":"41","author":"Valentin","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104721_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10815-007-9128-7","article-title":"Transvaginal ultrasound assessment of the premenopausal ovarian mass","volume":"24","author":"Cohen","year":"2007","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104721_bib25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ijgc-2022-003753","article-title":"Psychological impact of referral to an oncology hospital on patients with an ovarian mass","volume":"33","author":"Lof","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"44","key":"10.1016\/j.ijgc.2026.104721_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22440","article-title":"Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis","volume":"22","author":"Westwood","year":"2018","journal-title":"Health Technol Assess"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26002525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:22:09Z","timestamp":1785356529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26002525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1048891X26002525"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104721","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4 and risk of malignancy index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch health care perspective","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104721"}}